Pt hx: metastatic colon adenocarcinoma with solitary omental metastasis, all visible disease resected. Underwent prophylactic HIPEC on 03-13-2018 as part of a trial. Experienced dose delays for Xelox due to low platelet and ANC counts, with GCSF administered prior to the fourth cycle. Histopathology from left pelvic peritoneum and omentum showed no malignancy. Recent blood tests: ANC 0.96, PLt 121k, and CEA 6.4. CT TAP on 07-09-2018: no local recurrence, smaller pulmonary nodules, less prominent rectal mural thickening, and no new distant metastasis. Pt tolerating chemotherapy well with grade 1 neuropathy and stable weight, ECOG performance status 1. Management plan: proceed with sixth cycle of Xelox, continued home BP monitoring, and repeat CT after current cycle to assess lung lesions
